Audio
When Katherine Morgan was diagnosed with myeloma in 2008, her biggest concern was if she would be able to continue with her life as she knew it. Photography was her passion, and she was also concerned about being around her beautiful children and grandchildren, who always have runny noses, etc…
Videos
In this week’s #AskDrDurie, IMF Chairman Dr. Brian G.M.Durie takes a question from a patient who has both myeloma and bipolar disorder. She wants to know what treatment options she has for myeloma, given that she is on medication to treat her bipolar disorder, as well. Dr. Durie offers his advice,…
News Article
North Hollywood, CA, March 31, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – is proud to announce another successful “Myeloma Awareness Month” (#MAM) during March 2015.
The…
News Article
North Hollywood, CA, March 27, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – today commended Representative Brian Higgins (D-NY) for introducing a federal resolution (H. Res.…
Videos
In this week’s episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie looks at the factors of myeloma that affect the choice of treatment, including the type of myeloma and any chromosome abnormalities, as well as genetic testing done on the patient.
Videos
In this episode of the IMF's weekly web series, #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses his recommendation for use of the antibiotic Biaxin for patients with myeloma.
This week’s #AskDrDurie is about the antibiotic Biaxin. The patient is anxious to know, ‘What is the…
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses treatment options available for those myeloma patients with the t(4;14) abnormality, including IMiDs, next-generation proteasome inhibitors, novel combination therapies, and autologous stem cell transplants.
DR. DURIE:…
Videos
In this episode of the IMF’s weekly web series, #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie explains what dysplasia means when it shows up on a bone marrow report.
Transcript
DR. DURIE: This week’s #AskDrDurie question is about the bone marrow report, and the patient asks, ‘What does it…
Videos
In this episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie discusses the use of gadolinium in MRI testing, specifically for patients with abnormal kidney function.
Videos
In this week's episode of #AskDrDurie, IMF Chairman Dr. Brian G.M. Durie answers a patient's question about levels of bone density and how they connect to myeloma.
News Article
Q. How are the drugs approved in 2015 used in treatment?
A. In approving Farydak® (panobinostat), Darzalex® (daratumumab), Ninlaro® (ixazomib), and Empliciti® (elotuzumab) in 2015, the US Food and Drug Administration (FDA) broke with precedent and…
News Article
North Hollywood, CA, November 5, 2015 – The International Myeloma Foundation (IMF) – improving the quality of life of myeloma patients while working toward prevention and a cure – is thrilled to announce that this NBA season the organization’s research and education programs…
Videos
Register NOW for the FREE IMF Virtual Myeloma Community Workshop August 24, 20263:00 PM PT / 4:00 PM MT5:00 PM CT / 6:00PM ET The Virtual Myeloma Community Workshop will focus on topics concerning relapsed/refractory myeloma patients. Learn more about treatment response, disease…